Date of Procedure

 

Specimens Submitted:

1: SP: Leﬁt adnexal (Es)

2: SP: Supracolic omental nodule (is)

3: SP: Enlarged left external iliac lymph node (is)
4: SP: Left cul de sac nodule (fs)

5: SP: High left para-aortic lymph node (ts)
6: SP: Small bowel nodule

7: SP: Additional left I? lilgament

8: SP: Left pelvic sidewall nodule

9: SP: Uterus, cervix, right tube and ovary
10: SP: Additional cul-de-sac nodule

11: SP: Posterior cul-de-sac biopsy

12: SP: Left pelvic biopsy

13: SP: Right pelvic biopsy

14 SP: Left external iliac lymph node

15 SP: Left obturetor lymph node

16 SP: Right external iliac lymph node

17 SP: Right obturutor lymph node

18 SP: Anterior abdominal wall biopsy

19 SP: Left parecolic gutter biopsy

20 SP: Left diaphragm biopsy

21 SP: Omentum

22 SP: Right abdominal adhesion

23 SP: Right paracolic gutter biopsy

24 SP: Right diaphragm biopsy

25 SP: High right para-aortic lymph node
26 SP: Left para-aortic lymph node

27 SP: Left portacaval lymph node

23 SP: Right portacaval lymph node
DIAGNOSIS:

l . LEFT ADN'EXA , SALP INGO - OOPHORECTOH! :

— HIGH GRADE SBROUS CARCINOMA OF THE OVARY

FALLOPIAN TUBE WITH HYDROSALPINX AND CHRONIC SALPINGITIS

- PERIADENXAL LEIOMYOMA

** Continued on next page *‘

UUID: 867517DE— A483- 4563- 8698- 51CBQSDC5CF1d
TCGA- 13- ASFT- 91A- PR

ted
III IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII III

I II IIIIIIIIIIIIIIIIIIIIIIIII IIIIIII
IIIIIIIIIIIIIIIIIIIIIIIIIIIIII||||||||lI|IlI||||||||||III|III|l|

fab-0'3

dlfcmo M,W% N65
Wax/3

6H2: Ow ,C‘Slgﬁ
QIBZVz/Is

 

2. SUPRACOLIC OMENTAL NODULE. EXCISION:
- THREE BENIGN LYMPH NODES (0/3)

3. LIMPE NODE, ENLARGED LEFT EXTERNAL ILIAC. EXCISION:
- TWO BENIGN LIMPH NODBS (0/2)

4. LEFT CUL DE SAC NODULE, EXCISION:
— HIGH GRADE SEROUS CARCINOMA INVOLVING FIBROADIPOSE TISSUE

5. LYMPH NODE, HIGH LEFT PARA-AORTIC, EXCISION:
- HIGH GRADE SEROUS CARCINOMA INVOLVING ONE LIMPH NUDE (1/1)

6. SMALL BOWEL NODULE. EXCISION:
- BENIGN MESOTHELIAL INCLUSION CYST

7. LEFT IP LIGAMBNT, ADDITIONAL, BIOPSY:
- BENIGN FIBROADIPOSE TISSUE

3. LEFT PELVIC SIDEWALL NODULE. BIOPSY:
- HIGH GRADE SEROUS CARCINOMA INVOLVING FIBROADIPOSE TISSUE

9. UTERUS, CERVIX, RIGHT TUBE AND OVARY, TOTAL HYSTERECTOMY, RIGHT
SALPINGO-OOPHORECTOMY:

— HIGH GRADE SEROUS CARCINOMA INVOLVING OVARY AND FALLOPIAN TUBE

— HYOMETRIUM WITH LEIOMYOMA

- NEARLY PROLIFERATIVE ENDOMETRIUM

— UNREMARKABLE CERVIX

10. ANTBRIOR CUL-DE-SAC NODULE. BIOPSY:
- ONE BENIGN LYMPH NOD! (0/1)

11. POSTERIOR CUL-DE-SAC, BIOPSY:
- BENIGN FIBROADIPOSE TISSUE

12. LEFT PELVIC, BIOPSY:
- BENIGN FIBROADIPOSE TISSUE

13. RIGHT PELVIC, BIOPSY:
- BENIGN FIBROADIPSE TISSUE

14. LYHPH NUDE, LEFT EXTERNAL ILIAC. EXCISION:
- BENIGN FIEROADIPOSE TISSUE; NO LYMPHOID TISSUE IDENTIFIED IN
ENTIRELY SUBMITTED SPECIMEN

15. LYHPH NODE, LEFT OBTURATOR. BXCISION:
— FOUR BENIGN LYMPH NODES (0/4)

16. LIMPH NODB, RIGHT EXTERNAL ILIAC, EXCISION:
- ONE BENIGN LYMPH NODE (0/1)

17. LYMPH mops. RIGHT OBTURATOR, sxcxsxon:
- 51x BENIGN LYMPH nouns (0/6)

13. ANTERIOR ABDOMINAL WALL, BIOPSY:
- BENIGN FIBROADIPOSE TISSUE

“I Continued on next page '1'

 

19. LEFT PARACOLIC GUTTER, BIOPSY:
- BENIGN FIBROADIPOSE TISSUE

20. LEFT DIAPHRAGM, BIOPSY:
- BENIGN FIBROADIPOSE TISSUE

21. OMENTUM, RESECTION:
- BENIGN FIBROADIPOSE TISSUE
- TWO BENIGN LYMPH NODES (0/2)

22. RIGHT ABDOMINAL ADHESION. BIOPSY:
- BENIGN FIBROADIPOSE TISSUE

23. RIGHT PARACOLIC GUTTER, BIOPSY:
- BENIGN FIBROADIPOSE TISSUE

24. RIGHT DIAPHRAGM, BIOPSY:
- BENIGN SKELETAL MUSCLE AND PIBROADIPOSE TISSUE

25. LYMPH NODE, HIGH RIGHT PARA-AORTIC. EXCISION:
- FOUR BENIGN LYNPH NODES (0/4)

26. LIMPH NUDE, LEFT PARA-AORTIC. EXCISION:
— ONE BENIGN LYMPH NODE (0/1)

27. LYMPH NUDE, LEFT PORTACAVAL, BXCISION:
- one BENIGN LY‘MPH NODB (0/1)

28. LYMPH NODE, RIGHT PORTACAVAL, EXCISION:
- TWO BENIGN LIMPH NODES (0/2)

I ATTEST THAT THE ABOVE DIAGNOSIS IS BASED UPON MY PERSONAL EXAMINATION OF
THE SLIDES {AND/OR OTHER MATERIAL). AND THAT I HAVE REVIEWED AND APPROVED
THIS REPORT.

*4” Report Electronically Signed Out N" -

 

(mm; élg [31413 [t l)’ h;
Diagngisglzcrcpmcv
I PrImary Tumor Sit: Dinrepaucv
Wﬂiimrepancv
Prim Malignancy Hlsmrv

 

 

 

 

 
   

 

Raucwcr IIIIﬁals

 

 

